Outset Medical, Inc.
OM
$15.04
-$1.02-6.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.97% | 2.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.97% | 2.79% | |||
| Cost of Revenue | 3.00% | -3.74% | |||
| Gross Profit | -2.30% | 15.34% | |||
| SG&A Expenses | 0.65% | -14.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.85% | -12.82% | |||
| Operating Income | -0.63% | 31.60% | |||
| Income Before Tax | -0.10% | 7.62% | |||
| Income Tax Expenses | 2,975.00% | -102.20% | |||
| Earnings from Continuing Operations | -0.57% | 8.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.57% | 8.24% | |||
| EBIT | -0.63% | 31.60% | |||
| EBITDA | -1.44% | 33.63% | |||
| EPS Basic | 49.76% | 12.14% | |||
| Normalized Basic EPS | 55.25% | 30.71% | |||
| EPS Diluted | 49.76% | 12.14% | |||
| Normalized Diluted EPS | 55.25% | 30.71% | |||
| Average Basic Shares Outstanding | 100.16% | 4.44% | |||
| Average Diluted Shares Outstanding | 100.16% | 4.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||